Established in 1977, Entod has always shown a strong commitment to Innovation & Quality in Ophthalmic, ENT and Paediatric medicines. Our commitment and dedication to consistently achieve the HIGHEST QUALITY INTERNATIONAL STANDARDS has won us the trust of many in the ophthalmic, ENT and respiratory fraternity.
Entod has been committed in collaborating with various medical fraternities in support of educational and professional development programmes and conferences. We want to make a real difference to medical practice and to the quality of medical care received by patients.
We incorporate the latest TECHNOLOGIES in pharmaceutical manufacturing and are proud that our products are manufactured at state-of-the-art internationally approved manufacturing facilities.
Entod is continually expanding its innovative product range, rapidly developing its R&D facilities and growing its sales field force globally. With several exciting new products, research projects and clinical initiatives in the pipeline, Entod´s global image is taking good shape.
Contact:
Address: Ashirwad building, S.V.Road, Opp. Badi Masjid, Bandra(W), Mumbai-400050 INDIA
Website: entodpharma.com
Email: feedback@entodpharma.com
Dr Suresh Advani, director of the department of Medical Oncology at Jaslok Hospital and Research Centre reviews the progress of medical oncology in India and talks over the significant contribution…
President of India’s Diabetes & Obesity Centre, Dr Brij Mohan has an extensive background in the field of diabetes, having served on the board of Diabetes India and as president…
A pioneer in caster oil-based chemicals and pharmaceutical-grade products, Jayant Agro-Organics accounts for some 35 to 40 percent of the global castor oil market. Chairman Abhay V. Udeshi explains the audit…
India’s National Chemical Laboratory (NCL), one of the most well-established labs in the wider Council of Scientific and Industrial Research (CSIR) network, has made some major contributions to improving the…
Sanjay Bhutani of Bausch & Lomb outlines why the medical devices sector in India is poised for substantial growth, bolstered by increased government support and a higher healthcare budget. He…
Regular contributor Brendan Shaw gives his informed take on how best international stakeholders can engage with India’s attempts to transform into a global pharma innovation powerhouse, Our greatest ability…
Dr Santosh Indraksha serves as Deputy Drugs Controller (India) for the Central Drugs Standard Control Organisation (CDSCO) under the Indian Ministry of Health and Family Welfare. As a representative of…
Clinical trials will be a pivotal part of India’s attempts to scale the global pharmaceutical value chain. Following a series of well-publicised scandals in the early 2010s, the country tightened…
Dr Viranchi Shah of Saga Lifesciences and the Indian Drug Manufacturers Association (IDMA) outlines the Indian pharmaceutical industry’s potential for growth and its role in global health initiatives. He highlights…
Drawing on a unique background in both medicine and law, Dr Milind Antani today leads the pharma and healthcare practice at Nishith Desai Associates, covering everything from regulatory work to…
J&J India’s Jayashri Kulkarni lays out her approach to comprehensive leadership, drawing on her diverse career history across various sectors; her mandate to leverage innovative assets to transform disease management…
Shailesh Siroya explains the rationale behind Bal Pharma’s strategic focus on niche products within the API segment, avoiding the broader, more competitive commodity markets and enabling it to establish a…
See our Cookie Privacy Policy Here
